Abstract:Parathyroid hormone (PTH) receptor (PTHR) is a medically important family B G Protein Coupled Receptor (GPCR) that primarily couples to Gs/cAMP and Gq/Ca2+ signaling pathways and has a central role in regulating Ca2+ homeostasis and bone turnover. PTHR is activated by two endogenous hormones, endocrine PTH and paracrine PTH related protein (PTHrP), but only PTH mediates prolonged activation of the receptor and sustained cAMP responses after receptor internalization to the endosomes. To investigate the structural basis of prolonged activation of PTHR, we employed cryo‐EM and solved the high resolution (3Å) structure of PTHR coupled to Gs and activated by long‐acting PTH (LA‐PTH), an analog of PTH that remarkably sustains endosomal PTHR signaling and induces significantly prolonged elevation in blood calcium in mice and monkeys. LA‐PTH binds the receptor as a single extended α‐helix with its N‐terminus inserted deep into the transmembrane domain (TMD) of the receptor, while positioning the extracellular domain (ECD) of PTHR perpendicular to the cell membrane. The receptor activating N‐terminal half of LA‐PTH forms a dense network of hydrophobic and polar interactions with receptor's TMD resulting in a tight binding and giving structural basis for remarkably sustained activation of PTHR by LA‐PTH. Binding of LA‐PTH activates the receptor by inducing partial unwinding of the C‐terminus of transmembrane helix 6 (TM6) and a sharp kink at the middle of this helix, a hallmark of family B GPCR activation. This results in a pronounced outward movement of TM6, opening the cytosolic cavity of the receptor, which allows subsequent G protein coupling. Additionally, our cryo‐EM data revealed structural dynamics of PTHR demonstrated by the ability of receptor ECD to adopt multiple conformational states. Together, these results reveal the structural determinants of PTHR signaling and provide a molecular framework for structure‐based design of novel therapeutics for osteoporosis and hypocalcaemia treatment.Support or Funding InformationNIH R01 DK116780, DK102495 and DK111427 awarded to JPV; the Jay and Betty Van Andel Foundation and NIH GM127710 grants awarded to EXThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation

Structural Basis of Activation and Sustained Signaling by the PTH Receptor

Structure and Dynamics of the Active Human Parathyroid Hormone Receptor-1.

Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1

Critical Extracellular Ca2+ Dependence of the Binding Between PTH1R and a G-Protein Peptide Revealed by MD Simulations.

Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models

Molecular Mechanism of Ca2+in the Allosteric Regulation of Human Parathyroid Hormone Receptor-1

Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2

Visualization of the Parathyroid Hormone Receptor in Long-Active States

Differential Effects of PTH (1-34), PTHrP (1-36), and Abaloparatide on the Murine Osteoblast Transcriptome

[Effect of signal-selective parathyroid hormone analogue peptide on expressions of Wnt signaling factors]

Dimeric PTH(1-34) Activates the Parathyroid Hormone-1 Receptor in vitro and Stimulates Bone Formation in Osteoporotic Female Mice

Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator

Effects of PTH glandular and external dosing patterns on bone cell activity using a two-state receptor model—Implications for bone disease progression and treatment

Structural Characterization of Human Parathyroid Hormone 1 Receptor

Short carboxyl terminal parathyroid hormone peptides modulate human parathyroid hormone signaling in mouse osteoblasts

Prolonged signaling of backbone-modified glucagon-like peptide-1 analogues with diverse receptor trafficking

Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling

Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone

Histological assessments for anabolic effects in teriparatide/abaloparatide administered rodent models

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.